Volume 50, Issue 1 pp. 90-97
Research Article

Complementary and alternative therapy use in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study

Ann C. Mertens PhD

Corresponding Author

Ann C. Mertens PhD

University of Minnesota, Minneapolis, Minnesota

Department of Pediatrics, University of Minnesota, MMC 715, 420 Delaware Street SE, Minneapolis, MN 55455.===Search for more papers by this author
Susan Sencer MD

Susan Sencer MD

Children's Hospitals and Clinics, Minneapolis, Minnesota

Search for more papers by this author
Cynthia D. Myers PhD

Cynthia D. Myers PhD

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida

Search for more papers by this author
Christopher Recklitis PhD

Christopher Recklitis PhD

Dana Farber Cancer Institute, Boston, Massachusetts

Search for more papers by this author
Nina Kadan-Lottick MD

Nina Kadan-Lottick MD

Yale University, New Haven, Connecticut

Search for more papers by this author
John Whitton MS

John Whitton MS

Fred Hutchinson Cancer Research Center, Seattle, Washington

Search for more papers by this author
Neyssa Marina MD

Neyssa Marina MD

Stanford University, Palo Alto, California

Search for more papers by this author
Leslie L. Robison PhD

Leslie L. Robison PhD

St. Jude Children's Research Hospital, Memphis, Tennessee

Search for more papers by this author
Lonnie Zeltzer MD

Lonnie Zeltzer MD

UCLA Medical Center, Los Angeles, California

Search for more papers by this author
First published: 19 November 2007
Citations: 31

Other investigators and institutions participating in the Childhood Cancer Survivors Study are listed in the Supplemental appendix.

Abstract

Background

Little information is available on the use of complementary and alternative medicine (CAM) in long-term survivors of childhood and adolescent cancer.

Procedure

The Childhood Cancer Survivor Study (CCSS) is a resource evaluating the long-term effects of cancer and associated therapies in 5-year survivors of childhood and adolescent cancer diagnosed between 1970 and 1986 before the age of 21 years. A survey of CAM use during the previous year was distributed in 2000–2001 and completed by 9,984 survivors and 2,474 sibling controls.

Results

CAM use reporting was similar in cases (39.4%) and siblings (41.1%). Compared to female siblings, female survivors were more likely to use biofeedback (odds ratio (OR) = 3.3; 95% CI = 1.0–10.8) and hypnosis/guided imagery (OR = 3.2; 95% CI = 1.6–6.8); male survivors were more likely than male siblings to use herbal remedies (OR = 1.3; 95% CI = 1.1–1.6). Factors associated with CAM use in survivors included elevated scores on the brief symptom inventory (BSI)-18 (OR = 1.6; 95% CI = 1.3–1.9), prolonged pain (OR  = 1.5; 95% CI = 1.3–1.7), and having seen a physician in the past 2 years (OR = 1.6; 95% CI = 1.4–1.8). Survivors reporting low alcohol intake and excellent or good general health reported lower levels of CAM use (OR = 0.7; 95% CI = 0.7–0.8 and OR = 0.8; 95% CI = 0.7–0.9, respectively).

Conclusions

Survivors have a similar reported use of CAM compared to a sibling cohort. However, our data suggest that survivors turn to CAM for specific symptoms related to previous diagnosis and treatment. Future research is needed to determine whether CAM use reflects unmet health needs in this population. Pediatr Blood Cancer 2008;50:90–97. © 2007 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.